BNP Paribas lifted its position in Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) by 7.3% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 31,694 shares of the medical equipment provider’s stock after acquiring an additional 2,153 shares during the quarter. BNP Paribas’ holdings in Intuitive Surgical were worth $12,888,000 as of its most recent SEC filing.
A number of other institutional investors and hedge funds also recently modified their holdings of ISRG. Dogwood Wealth Management LLC raised its stake in Intuitive Surgical by 178.3% during the third quarter. Dogwood Wealth Management LLC now owns 64 shares of the medical equipment provider’s stock worth $26,000 after acquiring an additional 41 shares during the period. North Point Portfolio Managers Corp OH bought a new stake in shares of Intuitive Surgical in the 3rd quarter worth approximately $27,000. John Boyer Inc. acquired a new position in Intuitive Surgical during the 3rd quarter valued at approximately $27,000. Compass Wealth Management LLC bought a new position in Intuitive Surgical during the 3rd quarter worth $29,000. Finally, Compass Financial Management LLC acquired a new stake in Intuitive Surgical in the second quarter worth $30,000. 83.64% of the stock is owned by institutional investors and hedge funds.
Key Stories Impacting Intuitive Surgical
These are some of the ISRG stories that stood out recently:
- Positive Sentiment: Industry coverage casts Intuitive Surgical as a leading beneficiary of expanding surgical-robotics adoption, citing growth in robotic procedures and use of its da Vinci system. A separate medical-device roundup also identifies ISRG as a stock to watch, though neither story reports a new company announcement. Surgical robotics industry article Medical-device stocks article
- Neutral Sentiment: An executive sold 46 shares under a pre-arranged Rule 10b5-1 plan. The transaction was small and scheduled in advance, so it is a limited signal about management’s outlook. Insider-sale report
- Negative Sentiment: ISRG was reported down 1.7% since its latest earnings report, suggesting the strong results have not yet translated into sustained share-price momentum. The article offers no fresh earnings-estimate change to clarify the potential for a rebound. Post-earnings performance article
Intuitive Surgical Stock Performance
Intuitive Surgical (NASDAQ:ISRG – Get Free Report) last announced its earnings results on Tuesday, October 20th. The medical equipment provider reported $3.00 EPS for the quarter, beating the consensus estimate of $2.65 by $0.35. Intuitive Surgical had a return on equity of 18.17% and a net margin of 25.54%. The business had revenue of $3.05 billion during the quarter, compared to the consensus estimate of $2.91 billion. During the same period in the prior year, the business posted $2.40 earnings per share. Intuitive Surgical’s revenue was up 21.7% compared to the same quarter last year. On average, research analysts predict that Intuitive Surgical, Inc. will post 9.37 earnings per share for the current fiscal year.
Analysts Set New Price Targets
A number of equities research analysts have issued reports on the company. Barclays reissued an “overweight” rating and set a $500.00 price target (up from $485.00) on shares of Intuitive Surgical in a report on Wednesday, October 21st. BTIG Research upped their target price on shares of Intuitive Surgical from $454.00 to $513.00 and gave the stock a “buy” rating in a research report on Wednesday. HSBC lowered shares of Intuitive Surgical from a “buy” rating to a “hold” rating and set a $391.00 price target on the stock. in a research note on Thursday, July 30th. Erste Group Bank raised Intuitive Surgical from a “hold” rating to a “buy” rating in a report on Wednesday, October 21st. Finally, Weiss Ratings reiterated a “hold (c)” rating on shares of Intuitive Surgical in a research report on Thursday, November 12th. One analyst has rated the stock with a Strong Buy rating, twenty-three have assigned a Buy rating, five have given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, Intuitive Surgical currently has a consensus rating of “Moderate Buy” and an average target price of $495.90.
Check Out Our Latest Report on Intuitive Surgical
Insider Activity at Intuitive Surgical
In related news, EVP Mark Brosius sold 61 shares of the stock in a transaction that occurred on Wednesday, October 28th. The stock was sold at an average price of $441.60, for a total value of $26,937.60. Following the transaction, the executive vice president owned 581 shares in the company, valued at approximately $256,569.60. This represents a 9.50% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, SVP Patricia Wadors sold 1,078 shares of the company’s stock in a transaction dated Friday, October 23rd. The stock was sold at an average price of $443.80, for a total value of $478,416.40. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last three months, insiders sold 39,363 shares of company stock worth $17,738,749. 0.60% of the stock is currently owned by corporate insiders.
Intuitive Surgical Company Profile
Intuitive Surgical develops, manufactures and markets robotic-assisted systems for minimally invasive procedures. Its products include da Vinci surgical systems, which allow surgeons to control instruments and a high-definition vision system from a console, as well as the Ion endoluminal system, designed to assist with minimally invasive lung biopsies. The company also provides instruments, accessories, training and support services for its systems. Its technology is used in a range of surgical specialties, including urology, general surgery and gynecology.
Featured Articles
- Five stocks we like better than Intuitive Surgical
- ZIM Just Posted Huge Profits, But Its $35 Buyout Is Still in Limbo
- Owens Corning’s Stock Slump May Have a Silver Lining for Dividend Investors
- The Patchpocalypse Could Be a Big Opportunity for These 2 Cybersecurity Stocks
- Anthropic’s Record IPO Could Ease a Major Concern for Broadcom Investors
Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report).
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.
